{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T04:28:02Z","timestamp":1782534482591,"version":"3.54.5"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004775","name":"Gansu Provincial Natural Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004775","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007062","name":"Yangzhou University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007764","name":"Lanzhou City Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007764","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajo.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.ajo.2024.02.038","type":"journal-article","created":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T16:18:02Z","timestamp":1709741882000},"page":"141-151","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["Efficacy of Intravitreal Injections Anti-Vascular Endothelial Growth Factor Treatment for Radiation Retinopathy: A Systematic Review and Meta-analysis"],"prefix":"10.1016","volume":"263","author":[{"given":"Jiayuan","family":"Zhuang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuexia","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenghao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-an","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangxia","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heng","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajo.2024.02.038_bib0001","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.canrad.2022.04.010","article-title":"Radiation-induced retinopathy: actual knowledge and new concepts","volume":"26","author":"Gilli","year":"2022","journal-title":"Cancer Radiother"},{"issue":"2","key":"10.1016\/j.ajo.2024.02.038_bib0002","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4143\/crt.2021.575","article-title":"Radiation-induced ocular surface disorders and retinopathy: ocular structures and radiation dose-volume effect","volume":"54","author":"Akagunduz","year":"2022","journal-title":"Cancer Res Treat"},{"issue":"23","key":"10.1016\/j.ajo.2024.02.038_bib0003","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1007\/s00018-021-03989-2","article-title":"Effect of space flight on the behavior of human retinal pigment epithelial arpe-19 cells and evaluation of coenzyme q10 treatment","volume":"78","author":"Cialdai","year":"2021","journal-title":"Cell Mol Life Sci"},{"issue":"3","key":"10.1016\/j.ajo.2024.02.038_bib0004","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ICU.0b013e3283386687","article-title":"Classification and treatment of radiation maculopathy","volume":"21","author":"Horgan","year":"2010","journal-title":"Curr Opin Ophthalmol"},{"issue":"4","key":"10.1016\/j.ajo.2024.02.038_bib0005","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/08820538.2021.2000623","article-title":"Radiation retinopathy intricacies and advances in management","volume":"37","author":"Garc\u00eda-O'Farrill","year":"2022","journal-title":"Semin Ophthalmol"},{"key":"10.1016\/j.ajo.2024.02.038_bib0006","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.exer.2019.01.019","article-title":"Animal models of radiation retinopathy\u2014from teletherapy to brachytherapy","volume":"181","author":"Ramos","year":"2019","journal-title":"Exp Eye Res"},{"issue":"8","key":"10.1016\/j.ajo.2024.02.038_bib0007","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1016\/S0161-6420(99)90455-4","article-title":"Risk factors for radiation maculopathy and papillopathy after intraocular irradiation","volume":"106","author":"Gragoudas","year":"1999","journal-title":"Ophthalmology"},{"issue":"12","key":"10.1016\/j.ajo.2024.02.038_bib0008","doi-asserted-by":"crossref","first-page":"e139202","DOI":"10.1172\/JCI139202","article-title":"Hif-1\u03b1 and hif-2\u03b1 redundantly promote retinal neovascularization in patients with ischemic retinal disease","volume":"131","author":"Zhang","year":"2021","journal-title":"J Clin Invest"},{"issue":"9","key":"10.1016\/j.ajo.2024.02.038_bib0009","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/archopht.1996.01100140299007","article-title":"Proliferative radiation retinopathy","volume":"114","author":"Kinyoun","year":"1996","journal-title":"Arch Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.02.038_bib0010","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/09286586.2020.1792937","article-title":"Real-world visual and neovascularisation outcomes from anti-VEGF in central retinal vein occlusion","volume":"28","author":"Hogg","year":"2021","journal-title":"Ophthalmic Epidemiol"},{"issue":"10","key":"10.1016\/j.ajo.2024.02.038_bib0011","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1080\/14712598.2022.2100694","article-title":"Efficacy and safety of intravitreal anti-VEGF therapy in diabetic retinopathy: what we have learned and what should we learn further?","volume":"22","author":"Uludag","year":"2022","journal-title":"Expert Opin Biol Ther"},{"issue":"6","key":"10.1016\/j.ajo.2024.02.038_bib0012","doi-asserted-by":"crossref","first-page":"850","DOI":"10.5301\/ejo.5000333","article-title":"High-dose (2.0 mg) intravitreal ranibizumab for recalcitrant radiation retinopathy","volume":"23","author":"Finger","year":"2013","journal-title":"Eur J Ophthalmol"},{"issue":"1","key":"10.1016\/j.ajo.2024.02.038_bib0013","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00417-021-05281-2","article-title":"Two-year results for ranibizumab for radiation retinopathy (RRR): a randomized, prospective trial","volume":"260","author":"Yu","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.02.038_bib0014","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1167\/iovs.64.7.35","article-title":"Randomized trial of treat-and-extend intravitreal aflibercept for radiation retinopathy: 1-year outcomes","volume":"64","author":"Trejo Corona","year":"2023","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"9","key":"10.1016\/j.ajo.2024.02.038_bib0015","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1097\/IAE.0000000000003105","article-title":"Eighteen-month results of intravitreal anti-vascular endothelial growth factor on vision and microcirculation in radiation maculipathy","volume":"41","author":"Eandi","year":"2021","journal-title":"Retina"},{"issue":"4","key":"10.1016\/j.ajo.2024.02.038_bib0016","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1007\/s00417-020-04618-7","article-title":"Influence of ranibizumab versus laser photocoagulation on radiation retinopathy (RadiRet)\u2014a prospective randomized controlled trial","volume":"258","author":"Seibel","year":"2020","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/j.ajo.2024.02.038_bib0017","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.ajo.2020.03.045","article-title":"Randomized trial of monthly versus as-needed intravitreal ranibizumab for radiation retinopathy-related macular edema: 1-year outcomes","volume":"216","author":"Schefler","year":"2020","journal-title":"Am J Ophthalmol"},{"issue":"8","key":"10.1016\/j.ajo.2024.02.038_bib0018","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/IAE.0000000000002200","article-title":"Intravitreal anti-vascular endothelial growth factor treatment at 2-month intervals reduces foveal avascular zone enlargement and vision loss in radiation maculopathy: a pilot study","volume":"39","author":"Daruich","year":"2019","journal-title":"Retina"},{"key":"10.1016\/j.ajo.2024.02.038_bib0019","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ajo.2016.04.024","article-title":"Antiangiogenic or corticosteroid treatment in patients with radiation maculopathy after proton beam therapy for uveal melanoma","volume":"168","author":"Seibel","year":"2016","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajo.2024.02.038_bib0020","first-page":"1739","article-title":"Early SD-OCT diagnosis followed by prompt treatment of radiation maculopathy using intravitreal bevacizumab maintains functional visual acuity","volume":"6","author":"Shah","year":"2012","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.02.038_bib0021","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1001\/jama.1981.03310370045029","article-title":"Considerations in the diagnosis of radiation injury","volume":"245","author":"Chacko","year":"1981","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.ajo.2024.02.038_bib0022","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"issue":"6","key":"10.1016\/j.ajo.2024.02.038_bib0023","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1111\/j.1475-1313.2010.00766.x","article-title":"Transforming scales of measurement of visual acuity at the group level","volume":"30","author":"Khoshnood","year":"2010","journal-title":"Ophthalmic Physiol Opt"},{"key":"10.1016\/j.ajo.2024.02.038_bib0024","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"Rob 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.ajo.2024.02.038_bib0025","doi-asserted-by":"crossref","first-page":"i4919","DOI":"10.1136\/bmj.i4919","article-title":"Robins-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.ajo.2024.02.038_bib0026","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/S0161-6420(00)00526-1","article-title":"Collaborative ocular melanoma study (coms) randomized trial of i-125 brachytherapy for medium choroidal melanoma. I. Visual acuity after 3 years coms report no. 16","volume":"108","author":"Melia","year":"2001","journal-title":"Ophthalmology"},{"issue":"Pt 5","key":"10.1016\/j.ajo.2024.02.038_bib0027","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/eye.1989.98","article-title":"Early ultrastructural changes after low-dose x-irradiation in the retina of the rat","volume":"3","author":"Amoaku","year":"1989","journal-title":"Eye (Lond)"},{"issue":"2","key":"10.1016\/j.ajo.2024.02.038_bib0028","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cyto.2014.08.005","article-title":"Vascular endothelial growth factor: therapeutic possibilities and challenges for the treatment of ischemia","volume":"71","author":"Crafts","year":"2015","journal-title":"Cytokine"},{"issue":"6","key":"10.1016\/j.ajo.2024.02.038_bib0029","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1001\/archopht.125.6.751","article-title":"Anti-vascular endothelial growth factor bevacizumab (avastin) for radiation retinopathy","volume":"125","author":"Finger","year":"2007","journal-title":"Arch Ophthalmol"},{"issue":"7","key":"10.1016\/j.ajo.2024.02.038_bib0030","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.oret.2019.02.009","article-title":"Aflibercept for radiation maculopathy study: a prospective, randomized clinical study","volume":"3","author":"Murray","year":"2019","journal-title":"Ophthalmol Retina"},{"issue":"1","key":"10.1016\/j.ajo.2024.02.038_bib0031","doi-asserted-by":"crossref","first-page":"60","DOI":"10.5301\/ejo.5000670","article-title":"Intravitreal anti-VEGF therapy for macular radiation retinopathy: a 10-year study","volume":"26","author":"Finger","year":"2016","journal-title":"Eur J Ophthalmol"},{"issue":"3","key":"10.1016\/j.ajo.2024.02.038_bib0032","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1159\/000448719","article-title":"High-dose (2.5 mg) intravitreal bevacizumab as rescue therapy for persistent postradiation cystoid macular edema","volume":"3","author":"Khan","year":"2017","journal-title":"Ocul Oncol Pathol"},{"key":"10.1016\/j.ajo.2024.02.038_bib0033","first-page":"1877","article-title":"Combination therapy with triamcinolone acetonide and bevacizumab for the treatment of severe radiation maculopathy in patients with posterior uveal melanoma","volume":"7","author":"Shah","year":"2013","journal-title":"Clin Ophthalmol"},{"issue":"12","key":"10.1016\/j.ajo.2024.02.038_bib0034","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1136\/bjophthalmol-2017-310315","article-title":"Intravitreal triamcinolone acetate for radiation maculopathy recalcitrant to high-dose intravitreal bevacizumab","volume":"101","author":"Kaplan","year":"2017","journal-title":"Br J Ophthalmol"}],"container-title":["American Journal of Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424000965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002939424000965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,10]],"date-time":"2024-11-10T01:00:26Z","timestamp":1731200426000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002939424000965"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":34,"alternative-id":["S0002939424000965"],"URL":"https:\/\/doi.org\/10.1016\/j.ajo.2024.02.038","relation":{},"ISSN":["0002-9394"],"issn-type":[{"value":"0002-9394","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of Intravitreal Injections Anti-Vascular Endothelial Growth Factor Treatment for Radiation Retinopathy: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajo.2024.02.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}